Bone Biologics (BBLGW) Assets (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Assets for 2 consecutive years, with $1.7 million as the latest value for Q3 2017.
- Quarterly Assets rose 116.3% to $1.7 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Sep 2017, up 116.3% year-over-year, with the annual reading at $701140.0 for FY2016, N/A changed from the prior year.
- Assets for Q3 2017 was $1.7 million at Bone Biologics, up from $868389.0 in the prior quarter.
- The five-year high for Assets was $4.3 million in Q1 2016, with the low at $701140.0 in Q4 2016.